हाल में देखा गया

  • होम
  • स्टोरी
  • News Announcement
  • Transgene Biotek: The Board Has Considered And Approved The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31.12.2024 In Accordance With The Indian Accounting Standards (IND-AS) As Per Companies (Indian Accounting Standards) Rules 2015.Limited Review Report On The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31.12.2024 Has Also Been Approved.
News Announcement

Transgene Biotek: The Board Has Considered And Approved The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31.12.2024 In Accordance With The Indian Accounting Standards (IND-AS) As Per Companies (Indian Accounting Standards) Rules 2015.Limited Review Report On The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 31.12.2024 Has Also Been Approved.

24-जनवरी-2025 Follow Value Research Online on Google download pdfडाउनलोड पीडीएफ़ Transgene Biotek

Financial Results 31-12-2024.

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.